This doesn’t surprise me a bit. People (like me) in the US are howling about their insurers not covering these outlandishly expensive drugs when they should be complaining about the manufacturer charging these ridiculous prices.
If insurers (both private & government) are forced to pay Gilead’s ransom, the cost will be passed right to their clients the next fiscal year in the form of premiums & taxes.
In the end, it only seems logical that the government pay Gilead the big bucks since the same government paid to research and develop its flagship product, sofosbuvir.
What a mess.
Thank God and James Freeman for generics.
m
